Litholink / Laboratory Corporation of America
Executive OfficesUnited States51-200 Employees
Litholink, also known as the Laboratory Corporation of America, operates in the executive offices sector with a focus on kidney stone testing and broader programs for chronic disease. Founded in 1996 by Dr. Fredric L. Coe, a Chicago-area medical professor, the company grew from a specialty in kidney stone prevention to serve major urology practices and academic medical centers across the United States, leveraging Dr. Coe’s lifelong research and NIH consensus leadership. In 2006, Litholink was acquired by Laboratory Corporation of America Holdings, and it continues to build programmatic approaches that expand its kidney stone testing program into comprehensive chronic disease management. The firm is based in the United States and maintains a workforce described as mid-sized, reflecting its continued focus on specialized services for clinicians and hospital-affiliated providers. A recent note indicates Litholink remains a leader in its core testing domain while pursuing broader program development in chronic disease care.